Philip founded Geneva Network in 2015. His main research interests are the intersection of intellectual property, trade, and health policy. Formerly he was an official at the World Intellectual Property Organization (WIPO) in Geneva, where he worked in its Global Challenges Division on a range of IP and health issues. Prior to his time with WIPO, Philip worked as director of policy for International Policy Network, a UK-based think tank, as well as holding research positions with the Adam Smith Institute and Reform, both in London. He has also worked as a political risk consultant and a management consultant. He is a regular columnist in a wide range of international newspapers and has published a number of academic studies. He holds degrees from the London School of Economics and Durham University (UK). He is also a Senior Fellow at the Institute for Democracy and Economic Affairs, Malaysia.
The Innovate4Health project tells the exciting story of people who are solving the world’s biggest health challenges with innovation. The innovations we have profiled have focused on local inventors, meeting local challenges.
For middle-income countries looking to diversify their economies and graduate to high-income status, IPRs are more important today than at any other point in history. Using compulsory licenses to achieve public health objectives is short-termist, anachronistic and counterproductive in the long run.
Much of the public discourse about free trade focuses on the supposed dangers it poses to the environment, to vulnerable communities around the world and to our health. Geneva Network has teamed up with the IFT to produce a pamphlet explaining the role of open trade in improving public health.
The Colombian government must look at healthcare as a powerful source of economic growth.
El presidente Iván Duque prometió, en campaña, aumentar el gasto en salud para hacerle frente a los retos del sistema: envejecimiento poblacional, mayor prevalencia de enfermedades crónicas y persistentes déficits financieros que agravan una deuda acumulada de $8 billones.
As South Africa looks to the future, it can learn from its BRICS partners. China’s focus on innovation, while simultaneously addressing access to medicines, means it is far more in tune with the twenty first century.
The OECD risks weakening its brand by permitting accession of a country that does not fully respect basic market institutions such as intellectual property rights, writes Philip Stevens.
Following growing concern about the sustainability of healthcare systems, in the summer of 2016 EU…
Asian thought leaders meet in Beijing to talk innovation, trade and health policy Many Asian…